2020 UK Automated Microbiology Market: Supplier Shares and Segmentation Forecasts for 100 Molecular Dx, Identification, Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests-Competitive Landscape, Innovative Technologies, Latest Instrumentation, Emerging Opportunities

February 2020 | 415 pages | ID: 259F088D98D5EN
Venture Planning Group

Abstracts

LeadingMarketResearch.com's new report is an analysis of major business opportunities emerging in the U.K. automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding U.K. microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Market Segmentation Analysis

• Sales and market shares for major suppliers by individual test.
• Volume and sales forecasts for over 100 infectious disease assays by individual test:
• Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
• Review of the market dynamics, trends, structure, size, growth and major suppliers.

Specimen Types

• Urine
• Sterile Fluids: Blood, Serum, CSF
• Throat Swabs, Respiratory Secretions
• Genital Secretions
• Stool
• Abscess/Wound
• Sputum
• Saliva

Applications

• Microbial Identification
• Antibiotic Susceptibility
• Urine Screening
• Blood Cultures

Review of Major Automated Systems

Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.

The report profiles analyzers manufactured by Abbott Laboratories, Agilent Technologies, Beckman Coulter/Danaher, bioMerieux, Bio-Rad, DiaSorin, Eiken Chemical, Fujirebio, Grifols, Instrumentation Laboratory/Werfen, Kyowa Medex, Ortho-Clinical Diagnostics, PerkinElmer, Quest Diagnostics, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Tosoh, Wako.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

• Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
• Global listings of companies developing or marketing microbiology products by individual test.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

The companies analyzed in the report include Abbott Laboratories, Agilent Technologies, Beckman Coulter/Danaher, bioMerieux, Bio-Rad, DiaSorin, Eiken Chemical, Fujirebio, Grifols, Instrumentation Laboratory/Werfen, Kyowa Medex, Ortho-Clinical Diagnostics, PerkinElmer, Quest Diagnostics, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Tosoh, Wako.

Opportunities and Strategic Recommendations

• Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
• Design criteria for decentralized testing products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Contains 415 pages and 72 tables

Contents

I. MARKET AND TECHNOLOGY OVERVIEW

A. Introduction
  1. Major Factors Affecting Market Penetration of Microbiology Instrumentation
  2. Traditional Practices
  3. Technological Challenges
  4. Automation: Impact on the Microbiology Laboratory and the Patient
B. Major Specimen Types
  1. Urine
  2. Sterile Fluids: Blood, Serum, and CSF
  3. Throat Swabs and Respiratory Secretions
  4. Genital Secretions
  5. Stool
  6. Abscess/Wound
  7. Sputum
  8. Saliva
C. Test Applications
  1. Microbial Identification
  2. Antibiotic Susceptibility
  3. Urine Screening
    a. Photometry
    b. Bioluminescence
    c. Colorimetric Filtration
    d. Enzymatic Detection
    e. Optical Detection
  4. Blood Cultures
D. Major Microbiology Automated and Semiautomated Systems
  1. Multiple Purpose Microbiology Systems
  2. Specialized Microbiology Systems
  3. Molecular Diagnostic Systems
  4. Immunodiagnostic Systems
E. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
    a. DNA Sequencing
      Introduction
      Sequencing Methods
      Autoradiography
      The Human Genome Project
      Sequencing Automation
      Image Scanners
      Fluorescent Detection
      Gene Profiling Gene
      Expression
      Polymorphism Screening
      Protein Interaction Networks
      b. DNA And RNA Probe Technology
      Basic Principles
      Probe Preparation
      The DNA Probe Test
        Sample Preparation
        Hybridization
        Separation
        Detection/Measurement
      Test Formats
        Filter Hybridization
        Southern Blot
        Northern Blot
        In Situ Hybridization
        Others
      Labeling Techniques
      Amplification Methods
        Polymerase Chain Reaction
          Temperature Cyclers
          PCR Variations
            Immuno-PCR
            QC-PCR
            DAP-PCR
        Strand Displacement Activation
        TMA
        Ligase Chain Reaction
        Branched DNA
          Hybridization Protection Assay
        Nucleic-Acid Sequence-Based Amplification
        Self-Sustained Sequence Replicase
        Others
          Ampliprobe
          CAR
          CAS
          CPT
          Dendritic Polymer Technology
          ISO-CR
          LAT
          Probe
          RAMP
          Repair Chain Reaction
          Rolling Circles
          Sequence Independent Gene Amplification
          Sequence Initiation Reaction
          SISPA
          Solid Phase Amplification
  c. Detection Technologies
    Radioactive Methods
      Overview
      Major Isotopes
        P-32
        S-35
        H-3
      I-125
      Non-Isotopic Methods
        Enzymatic Labels
        Chemical Labeling
          Indirect Chemical Labeling
          Direct Chemical Labeling
        Fluorescence
        Chemiluminescence
        Electrical Conductivity
    d. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
      Liquid Transportation and Mixing
      Separation
      Reaction
      Detection
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

II. COUNTRY ANALYSIS

A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. COMPETITIVE ASSESSMENTS

Abbott Laboratories
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako